[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4976 Introduced in House (IH)]






108th CONGRESS
  2d Session
                                H. R. 4976

      To amend title 10, United States Code, to require emergency 
contraception to be included on the uniform formulary of pharmaceutical 
 agents of the pharmacy benefits program of the Department of Defense.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 22, 2004

Mr. Michaud (for himself, Ms. Slaughter, Ms. DeGette, and Mrs. Davis of 
 California) introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
      To amend title 10, United States Code, to require emergency 
contraception to be included on the uniform formulary of pharmaceutical 
 agents of the pharmacy benefits program of the Department of Defense.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REQUIREMENT TO INCLUDE EMERGENCY CONTRACEPTION ON UNIFORM 
              FORMULARY OF PHARMACEUTICAL AGENTS OF THE PHARMACY 
              BENEFITS PROGRAM OF THE DEPARTMENT OF DEFENSE.

    Section 1074g(a) of title 10, United States Code, is amended by 
adding at the end the following new paragraph:
    ``(9)(A) Emergency contraception shall be included on the uniform 
formulary.
    ``(B) Notwithstanding paragraph (4), no prior authorization may be 
required for emergency contraception. Nothing in the preceding sentence 
may be construed as waiving any provision of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 301 et seq.) or any other Act administered 
by the Food and Drug Administration.
    ``(C) In this paragraph, the term `emergency contraception' means a 
drug, drug regimen, or device that is--
            ``(i) used postcoitally;
            ``(ii) prevents pregnancy by delaying ovulation, preventing 
        fertilization of an egg, or preventing implantation of an egg 
        in a uterus; and
            ``(iii) is approved by the Food and Drug Administration.''.
                                 <all>